FBInvestor
Stocks / Halozyme Therapeutics Inc
Institutional Ownership

Halozyme Therapeutics Inc

CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon